USE OF BRONCHO-MUNAL FOR PNEUMONIA IN FREQUENTLY ILL CHILDREN
Abstract
The current importance of studying approaches to treating frequently ill children is extremely important, driven by the widespread prevalence of various illnesses in early childhood and the tendency for bronchopulmonary diseases to become chronic. Approximately half of pneumonia cases in children are caused by viruses, particularly the respiratory syncytial virus (RSV), which has a high tropism for the epithelium of the bronchopulmonary tract. Pneumonia remains one of the most significant problems in modern medicine and pediatrics, occupying a leading position among causes of morbidity and mortality. The disease poses a particular danger to children under 5 years of age, as their immune systems are still developing, and clinical manifestations are often atypical, complicating early diagnosis and timely treatment. Growing resistance of pathogens to antibacterial drugs is of significant importance, leading to an increase in the incidence of severe and protracted forms of the disease, complications, and deaths. Furthermore, pneumonia often develops alongside viral respiratory infections, allergic diseases, and chronic illnesses, which further complicates its course.